Document is current

Any future updates will be listed below

Correction: Clinical and urodynamic benefit of adding antimuscarinics after a loss of efficacy of intradetrusor botulinum toxin in patients with multiple sclerosis

Crossref DOI link: https://doi.org/10.1007/s00345-025-05972-z

Published Online: 2025-09-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark